✦ LIBER ✦

Difference in patient's acceptance of early versus late initiation of psychosocial support in breast cancer

✍ Scribed by Christine Scholten; Georg Weinländer; Michael Krainer; Oskar Frischenschlager; Christoph C. Zielinski

Publisher: Springer-Verlag
Year: 2001
Tongue: English
Weight: 66 KB
Volume: 9
Category: Article
ISSN: 0941-4355
DOI: 10.1007/s005200000233

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Chemotherapy versus tamoxifen versus che

Chemotherapy versus tamoxifen versus chemotherapy plus tamoxifen in node-positive, oestrogen receptor-positive breast cancer patients. Very late results of the ‘gruppo di ricerca per la chemio-ormonoterapia adiuvante (GROCTA)’ 01-Trial in early breast cancer

✍ Francesco Boccardo; Pamela Guglielmini; Andrea Parodi; Alessandra Rubagotti 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 535 KB

Homeostasis of peripheral FoxP3+CD4+regu

Homeostasis of peripheral FoxP3+CD4+regulatory T cells in patients with early and late stage breast cancer

✍ Andrew J. Rech; Rosemarie Mick; David E. Kaplan; Kyong-Mi Chang; Susan M. Domche 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 549 KB

The effects of mindfulness-based stress

The effects of mindfulness-based stress reduction on psychosocial outcomes and quality of life in early-stage breast cancer patients: a randomized trial

✍ Virginia P. Henderson; Lynn Clemow; Ann O. Massion; Thomas G. Hurley; Susan Druk 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 582 KB

Cost-effectiveness of letrozole versus t

Cost-effectiveness of letrozole versus tamoxifen as initial adjuvant therapy in postmenopausal women with hormone-receptor positive early breast cancer from a Canadian perspective

✍ Thomas E. Delea; Khalid El-Ouagari; Jonathan Karnon; Oleg Sofrygin 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 301 KB

Human epidermal growth factor receptor 2

Human epidermal growth factor receptor 2 expression in early breast cancer patients: a Swiss cost–effectiveness analysis of different predictive assay strategies

✍ Patricia R. Blank; Matthias Schwenkglenks; Holger Moch; Thomas D. Szucs 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 374 KB

Treatment of tumour-induced hypercalcaem

Treatment of tumour-induced hypercalcaemia in advanced breast cancer patients with three different doses of disodium pamidronate adapted to the initial level of calcaemia

✍ Z. Neškovié-Konstantinovié; L. Mitrovié; J. Petrovié; L. Stamatovié; Z. Ristovié 📂 Article 📅 1995 🏛 Springer-Verlag 🌐 English ⚖ 312 KB

A group of 38 female patients with advanced breast cancer experiencing the first occurrence of tumour-induced hypercalcaemia (TIH), mostly with osteolytic progressive bone metastases, were included in a prospective calcaemiaadapted study using three different doses of pamidronate (30 mg, 45 mg and 6